REQUEST A DEMO
Total
USD $0.00
Search more companies

Sureste Efectclin S.A.S. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Sureste Efectclin S.A.S. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Sureste Efectclin S.A.S. is a company based in Ecuador, with its head office in Quito. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The company was established on January 21, 2014. 4 (2024) employees currently work for Sureste Efectclin S.A.S.. The company’s latest financial report indicates a net sales revenue drop of 38.25% in 2024. Over the same period, its total assets grew by 97.84%. In 2024, Sureste Efectclin S.A.S.’s net profit margin increased by 5.82%.

Headquarters
Isidro Otero N44-188
Quito; Pichincha;

Contact Details: Purchase the Sureste Efectclin S.A.S. report to view the information.

Website: http://www.sureste.org

Basic Information
Total Employees:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Registered Capital:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Financial Auditors:
Purchase the Sureste Efectclin S.A.S. report to view the information.
Incorporation Date:
January 21, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
71.43%
Purchase this report to view the information.
14.29%
Purchase this report to view the information.
14.29%
Company Performance
Financial values in the chart are available after Sureste Efectclin S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-38.25%
Total operating revenue
-38.25%
Operating profit (EBIT)
33.06%
EBITDA
12.3%
Net Profit (Loss) for the Period
33.06%
Total assets
97.84%
Total equity
113.41%
Operating Profit Margin (ROS)
7.46%
Net Profit Margin
5.82%
Return on Equity (ROE)
-32.09%
Quick Ratio
2.51%
Cash Ratio
3.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?